Awaiting product image

Retatrutide (LY3437943)

+ Free Shipping

Retatrutide is a next-generation triple receptor agonist (GLP-1/GIP/Glucagon) supplied as a lyophilised research peptide. Available in 10mg and 20mg vials. ≥99% purity, third-party HPLC tested. For in vitro research use only.

This product is currently out of stock and unavailable.

Research Use Disclaimer This product is supplied exclusively for in vitro research and laboratory purposes. It is not intended for human or animal consumption, therapeutic use, or self-administration. Not evaluated by the TGA. By purchasing, you confirm you are a qualified researcher and accept full responsibility for handling and use.
SKU: ANX-RETA Category: Tag:
Guaranteed Safe Checkout

Retatrutide (LY3437943) — Research Grade | 10mg / 20mg

Retatrutide represents the cutting edge of incretin-based metabolic research. Originally developed by Eli Lilly, it is a synthetic peptide designed as a simultaneous agonist of three key receptors: GLP-1 (glucagon-like peptide-1), GIP (glucose-dependent insulinotropic polypeptide), and the glucagon receptor. This triple mechanism distinguishes it from earlier generation compounds such as semaglutide (GLP-1 only) and tirzepatide (GLP-1/GIP), making it a compound of significant interest in advanced metabolic and obesity research.

In laboratory research models, retatrutide has been explored for its potential role in appetite regulation, energy expenditure, fat metabolism, hepatic lipid reduction, and glucose homeostasis. Its glucagon receptor activity, absent in prior generation GLP-1 compounds, is of particular research interest for its potential contribution to thermogenesis and energy output.

Each AuroraNX vial is supplied as a white lyophilised powder, sealed under nitrogen, and is stable at room temperature during transit. Upon arrival, store refrigerated at 2–8°C. Reconstitute with bacteriostatic water prior to use.

Specifications

  • Sequence: LY3437943
  • Purity: ≥99% (HPLC verified, COA available)
  • Form: Lyophilised powder
  • Vial sizes: 10mg / 20mg
  • Storage: Refrigerate at 2–8°C post-reconstitution
Research Use Disclaimer This product is supplied exclusively for in vitro research and laboratory purposes. It is not intended for human or animal consumption, therapeutic use, or self-administration. AuroraNX does not provide medical advice. This product has not been evaluated or approved by the Therapeutic Goods Administration (TGA) or any other regulatory authority. By purchasing, the buyer confirms they are a qualified researcher, accepts full responsibility for handling and use, and agrees to AuroraNX Terms of Use.